Pamicogrel

N/A

Report date: 2022/02/17 16:56:12
NME

Base Information

Drug NamePamicogrel
Drug Alias Namepamicogrelum帕米格雷PaminateKBT-3022TO-192 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitorsCyclooxygenases inhibitors
TargetsArachidonate 5-lipoxygenaseCyclooxygenases
Therapy Area/IndicationsArterial Occlusive Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesTorii Pharmaceutical Co LtdAkzo Nobel
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTorii Pharmaceutical Co LtdAkzo Nobel
Active IndicationsN/A
Inactive IndicationsArterial Occlusive Diseases

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG